Who owns the BUCAPSOL trademark?

The BUCAPSOL trademark is owned by Pangea Pharmaceuticals, LLC.

What class is the BUCAPSOL trademark registered in?

The BUCAPSOL trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for BUCAPSOL?

The USPTO serial number for BUCAPSOL is 99113191.

What is the registration number for BUCAPSOL?

BUCAPSOL is registered under USPTO registration number 8359787.

Sealvo

Home Search: BUCAPSOLBUCAPSOL #99113191

Back

Updated Sep 19, 2026·38 searches this week

View on USPTO TSDR Find similar marks

BUC

USPTO Trademark Record

REGISTERED

BUCAPSOL

SN 99113191·Reg 8359787·Filed Mar 31, 2025

Owner Pangea Pharmaceuticals, LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

BUCAPSOL (Serial No. 99113191), Registration No. 8359787, is a registered US trademark filed on Mar 31, 2025 by Pangea Pharmaceuticals, LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: July 21, 2032

Conflict Analysis

Full conflict analysis for BUCAPSOL (SN 99113191) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

BUCAPSOL (Reg. #8359787) is a registered US trademark that has been protecting its owner, Pangea Pharmaceuticals, LLC, since 2025. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 31, 2025

SERIAL

99113191

REG#

8359787

REGISTERED

Jul 21, 2026

Filing Information

StatusREGISTERED

Filing DateMar 31, 2025

Serial Number99113191

Registration No.8359787

Registration DateJul 21, 2026

Status DateJul 21, 2026

Published for OppositionJul 22, 2025

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jul 11, 2025

First use in commerce: Jul 11, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

26 events

REGISTERED-PRINCIPAL REGISTER

Jul 21, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 21, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 02, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 02, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Apr 11, 2026

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 04, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Oct 09, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Oct 09, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 16, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jul 22, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 22, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 16, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 18, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 18, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 18, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 18, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

NON-FINAL ACTION WRITTEN

Jun 06, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jun 06, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 06, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jun 04, 2025

ASSIGNED TO EXAMINER

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

May 06, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

May 06, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 06, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NEW APPLICATION ENTERED

Mar 31, 2025

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 31, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Mar 31, 2025

APPLICATION FILING RECEIPT MAILED

Other Marks by Pangea Pharmaceuticals, LLC

Additional USPTO filings from the same owner.

QMI

QMIIZ

99735384

Pangea Pharmaceuticals, LLC

PENDING

PRI

PRIMSOL

99779392

Pangea Pharmaceuticals, LLC

PENDING

TRI

TRIMPEX

99799462

Pangea Pharmaceuticals, LLC

PENDING

QMI

QMIIZ

99735381

Pangea Pharmaceuticals, LLC

PENDING

Other Marks by David Sigmon

Additional USPTO filings handled by the same attorney of record.

ZEB

ZEBEDEE

99183170

REGISTERED

UNL

UNLIKELY PROFESSIONALS

99123366

REGISTERED

VEN

VENOM CARBON

87483108

REGISTERED

PED

PEDIATRIC PROCEDURE COZY

86212806

REGISTERED

BUCAPSOL

Run a conflict check

Other Marks by Pangea Pharmaceuticals, LLC

Other Marks by David Sigmon

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company